[MO-67] Presentation Awards
The outcome of endovascular therapy for iliac artery lesions involving common femoral artery
Background
Acceptable outcome of endovascular therapy (EVT) for iliac artery lesion has been reported, however, we feel that the EVT outcome of iliac artery lesion involving common femoral artery (CFA) is not good in daily practice.
Methods
This study is a single-center, retrospective study. We enrolled patients who underwent EVT for iliac artery lesions (166 patients and 214 limbs) between 2012 January and 2015 December. We divided them into two groups according to whether the lesion involving CFA or not. Primary endpoint was the rate of target lesion revascularization (TLR) at 3 years.
Results:
About patient and lesion characteristics, there was no significant difference in the rate of female (21.2% in iliac lesion not involving CFA vs. 19.1% in iliac lesion involving CFA, P=0.18), the rate of chronic total occlusion (9.6% vs. 16.2%, P=0.86), length of the lesion (40.4±22.8 vs. 32±29.0, P=0.25), and the rate of TASC C or D (28.1% vs. 38.2%, P=0.16). TLR at 3 years was significantly higher in the group of iliac lesions involving CFA (3.4% vs. 13.2%, P=0.005).
Conclusions:
In patients with iliac artery lesions involving CFA, the outcome of EVT was worse than that of the iliac lesions non involving CFA.
Acceptable outcome of endovascular therapy (EVT) for iliac artery lesion has been reported, however, we feel that the EVT outcome of iliac artery lesion involving common femoral artery (CFA) is not good in daily practice.
Methods
This study is a single-center, retrospective study. We enrolled patients who underwent EVT for iliac artery lesions (166 patients and 214 limbs) between 2012 January and 2015 December. We divided them into two groups according to whether the lesion involving CFA or not. Primary endpoint was the rate of target lesion revascularization (TLR) at 3 years.
Results:
About patient and lesion characteristics, there was no significant difference in the rate of female (21.2% in iliac lesion not involving CFA vs. 19.1% in iliac lesion involving CFA, P=0.18), the rate of chronic total occlusion (9.6% vs. 16.2%, P=0.86), length of the lesion (40.4±22.8 vs. 32±29.0, P=0.25), and the rate of TASC C or D (28.1% vs. 38.2%, P=0.16). TLR at 3 years was significantly higher in the group of iliac lesions involving CFA (3.4% vs. 13.2%, P=0.005).
Conclusions:
In patients with iliac artery lesions involving CFA, the outcome of EVT was worse than that of the iliac lesions non involving CFA.